Cornerstone Planning Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.03K Hold
36
﹤0.01% 921
2026
Q1
$6.66K Hold
36
﹤0.01% 1017
2025
Q4
$6.08K Sell
36
-1,791
-98% -$246K ﹤0.01% 925
2025
Q3
$204K Buy
1,827
+1,792
+5,120% +$127K 0.03% 134
2025
Q2
$2.25K Hold
35
﹤0.01% 909
2025
Q1
$1.86K Hold
35
﹤0.01% 1003
2024
Q4
$3.36K Hold
35
﹤0.01% 665
2024
Q3
$4.41K Sell
35
-1
-3% -$130 ﹤0.01% 590
2024
Q2
$3.96K Hold
36
﹤0.01% 623
2024
Q1
$3.83K Buy
36
+1
+3% +$131 ﹤0.01% 559
2023
Q4
$4.27K Hold
35
﹤0.01% 548
2023
Q3
$2.67K Hold
35
﹤0.01% 608
2023
Q2
$4.15K Buy
+35
New +$4.36K ﹤0.01% 952
2022
Q4
$4.47K Buy
+30
New +$4.18K ﹤0.01% 945

Other funds holding LABU

Cornerstone Planning Group's LABU Position: Q2 2026 in Review

Cornerstone Planning Group held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 36 shares worth $9.03K. The position accounts for ﹤0.01% of the portfolio, ranked #921.

Cornerstone Planning Group first reported a position in LABU in Q4 2022 and has held it in 14 quarters since. The position peaked at $204K in Q3 2025. 17 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Cornerstone Planning Group held 36 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $9.03K as of Q2 2026.
  • Cornerstone Planning Group left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #921 holding.
  • Cornerstone Planning Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $204K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.